Odeo

"antibody"

View all 47 episodes »

Episodes (47)

 
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News

Resolvyx Closes in on Clinical T...

8 days old

Adimab Closes Third VC Round

Adimab Closes Third VC Round

13 days old

Ascent Therapeutics Climbs Out of Stealth Mode with “Pepducins”

Ascent Therapeutics Climbs Out o...

17 days old

San Diego Makes Stem Cells a Rallying Cry for New Era in Life Sciences

San Diego Makes Stem Cells a Ral...

23 days old

 
Beyond Provenge: Dendreon Expands Cancer Drug Pipeline

Beyond Provenge: Dendreon Expand...

23 days old

Genzyme and Osiris Forge Stem-Cell Agreement, Xtalic Nabs $10M for Nano Alloys, Atlas Out for Half a Billion Bucks, & More Boston-Area Deals News

Genzyme and Osiris Forge Stem-Ce...

24 days old

Tysabri: The Big Multiple Sclerosis Drug That Emerged From “The Hutch”

Tysabri: The Big Multiple Sclero...

about 1 month old

Biogen Pays $31.5M to Genentech to Co-Develop Anti-CD20 Drug

Biogen Pays $31.5M to Genentech ...

about 1 month old

 
The radio wave Wizard John Kanzius

The radio wave Wizard John Kanzius

about 1 month old

Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividends

Amgen Scientist, After 13-Year P...

about 1 month old

Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments

Regulus, Leader in MicroRNA Drug...

about 1 month old

Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments

Alnylam–Isis Venture Regulus, Le...

about 1 month old

 
Optimer, Developer of Drug For “C. Diff” Bacteria, Awaits Pivotal Results

Optimer, Developer of Drug For “...

about 1 month old

Dying Cancer Patient Gets Tysabri After Biogen Idec’s Earlier Denial

Dying Cancer Patient Gets Tysabr...

about 1 month old

Cell Therapeutics, Still Fighting, Gets Zevalin Data Published In Cancer Journal

Cell Therapeutics, Still Fightin...

about 1 month old

Seattle Genetics Collects Payment From Progenics

Seattle Genetics Collects Paymen...

about 1 month old

 
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why

Biogen Turns Down Dying Patient’...

about 1 month old

New Pfizer Incubator Chief Looks Far and Wide for New Science, Yet Plans Off for Boston Site

New Pfizer Incubator Chief Looks...

about 1 month old

New Pfizer Incubator Chief Looks Far and Wide for New Science, But Backs Off Plans for Boston Site

New Pfizer Incubator Chief Looks...

about 1 month old

Avant Changes Name to Celldex Therapeutics, Hires Marucci as Permanent CEO

Avant Changes Name to Celldex Th...

2 months old